nodes	percent_of_prediction	percent_of_DWPC	metapath
Vismodegib—Sorafenib—liver cancer	0.73	1	CrCtD
Vismodegib—ALB—liver cancer	0.0844	1	CbGaD
Vismodegib—ABCG2—Sorafenib—liver cancer	0.0268	0.257	CbGbCtD
Vismodegib—ABCG2—Doxorubicin—liver cancer	0.0163	0.156	CbGbCtD
Vismodegib—CYP2C8—Sorafenib—liver cancer	0.0143	0.137	CbGbCtD
Vismodegib—CYP2C19—Sorafenib—liver cancer	0.012	0.115	CbGbCtD
Vismodegib—CYP2C9—Sorafenib—liver cancer	0.00997	0.0956	CbGbCtD
Vismodegib—ABCB1—Sorafenib—liver cancer	0.00968	0.0928	CbGbCtD
Vismodegib—ABCB1—Doxorubicin—liver cancer	0.00587	0.0563	CbGbCtD
Vismodegib—CYP3A4—Sorafenib—liver cancer	0.0058	0.0556	CbGbCtD
Vismodegib—CYP3A4—Doxorubicin—liver cancer	0.00352	0.0337	CbGbCtD
Vismodegib—Potassium low—Sorafenib—liver cancer	0.00299	0.121	CcSEcCtD
Vismodegib—ORM1—bile—liver cancer	0.00283	0.317	CbGeAlD
Vismodegib—Blood potassium decreased—Sorafenib—liver cancer	0.00165	0.0666	CcSEcCtD
Vismodegib—SHH—embryo—liver cancer	0.00163	0.183	CbGeAlD
Vismodegib—Etoricoxib—MAPK14—liver cancer	0.00123	0.433	CrCbGaD
Vismodegib—SMO—embryo—liver cancer	0.00114	0.128	CbGeAlD
Vismodegib—ORM1—gall bladder—liver cancer	0.000784	0.0881	CbGeAlD
Vismodegib—Neoplasm malignant—Sorafenib—liver cancer	0.000734	0.0297	CcSEcCtD
Vismodegib—ALB—gall bladder—liver cancer	0.000688	0.0773	CbGeAlD
Vismodegib—Musculoskeletal chest pain—Epirubicin—liver cancer	0.000597	0.0241	CcSEcCtD
Vismodegib—Musculoskeletal chest pain—Doxorubicin—liver cancer	0.000553	0.0223	CcSEcCtD
Vismodegib—SMO—liver—liver cancer	0.000526	0.0591	CbGeAlD
Vismodegib—Sorafenib—RAF1—liver cancer	0.000517	0.183	CrCbGaD
Vismodegib—Hyponatraemia—Sorafenib—liver cancer	0.000457	0.0185	CcSEcCtD
Vismodegib—Pain in extremity—Sorafenib—liver cancer	0.000455	0.0184	CcSEcCtD
Vismodegib—Dehydration—Sorafenib—liver cancer	0.000423	0.0171	CcSEcCtD
Vismodegib—Abdominal pain upper—Sorafenib—liver cancer	0.000415	0.0168	CcSEcCtD
Vismodegib—Hypokalaemia—Sorafenib—liver cancer	0.000414	0.0167	CcSEcCtD
Vismodegib—Breast disorder—Sorafenib—liver cancer	0.000411	0.0166	CcSEcCtD
Vismodegib—Aspartate aminotransferase increased—Sorafenib—liver cancer	0.00041	0.0166	CcSEcCtD
Vismodegib—Sorafenib—BRAF—liver cancer	0.000358	0.127	CrCbGaD
Vismodegib—Weight decreased—Sorafenib—liver cancer	0.000356	0.0144	CcSEcCtD
Vismodegib—Connective tissue disorder—Sorafenib—liver cancer	0.000309	0.0125	CcSEcCtD
Vismodegib—Sorafenib—KDR—liver cancer	0.000305	0.108	CrCbGaD
Vismodegib—Ageusia—Epirubicin—liver cancer	0.000286	0.0116	CcSEcCtD
Vismodegib—Alopecia—Sorafenib—liver cancer	0.000278	0.0112	CcSEcCtD
Vismodegib—Malnutrition—Sorafenib—liver cancer	0.000274	0.0111	CcSEcCtD
Vismodegib—Neoplasm malignant—Epirubicin—liver cancer	0.000271	0.011	CcSEcCtD
Vismodegib—Dysgeusia—Sorafenib—liver cancer	0.000268	0.0108	CcSEcCtD
Vismodegib—Ageusia—Doxorubicin—liver cancer	0.000264	0.0107	CcSEcCtD
Vismodegib—Amenorrhoea—Epirubicin—liver cancer	0.000264	0.0107	CcSEcCtD
Vismodegib—Muscle spasms—Sorafenib—liver cancer	0.000263	0.0106	CcSEcCtD
Vismodegib—Neoplasm malignant—Doxorubicin—liver cancer	0.000251	0.0101	CcSEcCtD
Vismodegib—Amenorrhoea—Doxorubicin—liver cancer	0.000244	0.00986	CcSEcCtD
Vismodegib—Musculoskeletal pain—Epirubicin—liver cancer	0.000234	0.00948	CcSEcCtD
Vismodegib—Arthralgia—Sorafenib—liver cancer	0.000233	0.00943	CcSEcCtD
Vismodegib—Myalgia—Sorafenib—liver cancer	0.000233	0.00943	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.000232	0.00936	CcSEcCtD
Vismodegib—Phosphatase alkaline increased—Epirubicin—liver cancer	0.000232	0.00936	CcSEcCtD
Vismodegib—ORM1—liver—liver cancer	0.00023	0.0258	CbGeAlD
Vismodegib—Etoricoxib—CYP2E1—liver cancer	0.000227	0.0803	CrCbGaD
Vismodegib—Nervous system disorder—Sorafenib—liver cancer	0.000219	0.00886	CcSEcCtD
Vismodegib—Blood urea increased—Epirubicin—liver cancer	0.000219	0.00884	CcSEcCtD
Vismodegib—Skin disorder—Sorafenib—liver cancer	0.000217	0.00878	CcSEcCtD
Vismodegib—Musculoskeletal pain—Doxorubicin—liver cancer	0.000217	0.00877	CcSEcCtD
Vismodegib—Phosphatase alkaline increased—Doxorubicin—liver cancer	0.000214	0.00866	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Sorafenib—liver cancer	0.000204	0.00824	CcSEcCtD
Vismodegib—Blood urea increased—Doxorubicin—liver cancer	0.000202	0.00818	CcSEcCtD
Vismodegib—ALB—liver—liver cancer	0.000202	0.0227	CbGeAlD
Vismodegib—Dyspepsia—Sorafenib—liver cancer	0.000197	0.00796	CcSEcCtD
Vismodegib—Sulfasalazine—PPARG—liver cancer	0.000196	0.0691	CrCbGaD
Vismodegib—Decreased appetite—Sorafenib—liver cancer	0.000194	0.00786	CcSEcCtD
Vismodegib—Blood alkaline phosphatase increased—Epirubicin—liver cancer	0.000193	0.00781	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Sorafenib—liver cancer	0.000193	0.0078	CcSEcCtD
Vismodegib—Fatigue—Sorafenib—liver cancer	0.000193	0.00779	CcSEcCtD
Vismodegib—Constipation—Sorafenib—liver cancer	0.000191	0.00773	CcSEcCtD
Vismodegib—Pain—Sorafenib—liver cancer	0.000191	0.00773	CcSEcCtD
Vismodegib—Gastrointestinal pain—Sorafenib—liver cancer	0.000183	0.00739	CcSEcCtD
Vismodegib—Blood alkaline phosphatase increased—Doxorubicin—liver cancer	0.000179	0.00723	CcSEcCtD
Vismodegib—Abdominal pain—Sorafenib—liver cancer	0.000177	0.00715	CcSEcCtD
Vismodegib—Hyponatraemia—Epirubicin—liver cancer	0.000169	0.00682	CcSEcCtD
Vismodegib—Pain in extremity—Epirubicin—liver cancer	0.000168	0.0068	CcSEcCtD
Vismodegib—CYP2C19—liver—liver cancer	0.000162	0.0182	CbGeAlD
Vismodegib—Asthenia—Sorafenib—liver cancer	0.00016	0.00649	CcSEcCtD
Vismodegib—Pruritus—Sorafenib—liver cancer	0.000158	0.0064	CcSEcCtD
Vismodegib—Dehydration—Epirubicin—liver cancer	0.000156	0.00632	CcSEcCtD
Vismodegib—Hyponatraemia—Doxorubicin—liver cancer	0.000156	0.00631	CcSEcCtD
Vismodegib—Pain in extremity—Doxorubicin—liver cancer	0.000156	0.00629	CcSEcCtD
Vismodegib—Abdominal pain upper—Epirubicin—liver cancer	0.000154	0.00621	CcSEcCtD
Vismodegib—Hypokalaemia—Epirubicin—liver cancer	0.000153	0.00619	CcSEcCtD
Vismodegib—Diarrhoea—Sorafenib—liver cancer	0.000153	0.00618	CcSEcCtD
Vismodegib—Breast disorder—Epirubicin—liver cancer	0.000152	0.00614	CcSEcCtD
Vismodegib—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.000151	0.00612	CcSEcCtD
Vismodegib—ABCB1—embryo—liver cancer	0.000147	0.0165	CbGeAlD
Vismodegib—Dehydration—Doxorubicin—liver cancer	0.000145	0.00585	CcSEcCtD
Vismodegib—Vomiting—Sorafenib—liver cancer	0.000142	0.00575	CcSEcCtD
Vismodegib—Abdominal pain upper—Doxorubicin—liver cancer	0.000142	0.00574	CcSEcCtD
Vismodegib—CYP2C8—liver—liver cancer	0.000142	0.0159	CbGeAlD
Vismodegib—Hypokalaemia—Doxorubicin—liver cancer	0.000142	0.00572	CcSEcCtD
Vismodegib—Rash—Sorafenib—liver cancer	0.000141	0.0057	CcSEcCtD
Vismodegib—Dermatitis—Sorafenib—liver cancer	0.000141	0.00569	CcSEcCtD
Vismodegib—Breast disorder—Doxorubicin—liver cancer	0.000141	0.00568	CcSEcCtD
Vismodegib—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.00014	0.00566	CcSEcCtD
Vismodegib—ABCG2—liver—liver cancer	0.000138	0.0155	CbGeAlD
Vismodegib—Nausea—Sorafenib—liver cancer	0.000133	0.00537	CcSEcCtD
Vismodegib—Weight decreased—Epirubicin—liver cancer	0.000131	0.00531	CcSEcCtD
Vismodegib—CYP2C9—liver—liver cancer	0.000126	0.0141	CbGeAlD
Vismodegib—Weight decreased—Doxorubicin—liver cancer	0.000122	0.00492	CcSEcCtD
Vismodegib—Connective tissue disorder—Epirubicin—liver cancer	0.000114	0.00462	CcSEcCtD
Vismodegib—Connective tissue disorder—Doxorubicin—liver cancer	0.000106	0.00428	CcSEcCtD
Vismodegib—Alopecia—Epirubicin—liver cancer	0.000103	0.00416	CcSEcCtD
Vismodegib—Malnutrition—Epirubicin—liver cancer	0.000101	0.00409	CcSEcCtD
Vismodegib—Dysgeusia—Epirubicin—liver cancer	9.91e-05	0.00401	CcSEcCtD
Vismodegib—Back pain—Epirubicin—liver cancer	9.79e-05	0.00396	CcSEcCtD
Vismodegib—Muscle spasms—Epirubicin—liver cancer	9.73e-05	0.00394	CcSEcCtD
Vismodegib—CYP3A4—liver—liver cancer	9.6e-05	0.0108	CbGeAlD
Vismodegib—Alopecia—Doxorubicin—liver cancer	9.51e-05	0.00384	CcSEcCtD
Vismodegib—Malnutrition—Doxorubicin—liver cancer	9.37e-05	0.00379	CcSEcCtD
Vismodegib—Dysgeusia—Doxorubicin—liver cancer	9.17e-05	0.00371	CcSEcCtD
Vismodegib—Back pain—Doxorubicin—liver cancer	9.06e-05	0.00366	CcSEcCtD
Vismodegib—Muscle spasms—Doxorubicin—liver cancer	9.01e-05	0.00364	CcSEcCtD
Vismodegib—Arthralgia—Epirubicin—liver cancer	8.62e-05	0.00348	CcSEcCtD
Vismodegib—Myalgia—Epirubicin—liver cancer	8.62e-05	0.00348	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	8.56e-05	0.00346	CcSEcCtD
Vismodegib—Nervous system disorder—Epirubicin—liver cancer	8.1e-05	0.00328	CcSEcCtD
Vismodegib—Skin disorder—Epirubicin—liver cancer	8.02e-05	0.00324	CcSEcCtD
Vismodegib—Arthralgia—Doxorubicin—liver cancer	7.97e-05	0.00322	CcSEcCtD
Vismodegib—Myalgia—Doxorubicin—liver cancer	7.97e-05	0.00322	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	7.92e-05	0.0032	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Epirubicin—liver cancer	7.53e-05	0.00304	CcSEcCtD
Vismodegib—Nervous system disorder—Doxorubicin—liver cancer	7.5e-05	0.00303	CcSEcCtD
Vismodegib—Skin disorder—Doxorubicin—liver cancer	7.43e-05	0.003	CcSEcCtD
Vismodegib—Dyspepsia—Epirubicin—liver cancer	7.27e-05	0.00294	CcSEcCtD
Vismodegib—Decreased appetite—Epirubicin—liver cancer	7.18e-05	0.0029	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Epirubicin—liver cancer	7.13e-05	0.00288	CcSEcCtD
Vismodegib—Fatigue—Epirubicin—liver cancer	7.12e-05	0.00288	CcSEcCtD
Vismodegib—Pain—Epirubicin—liver cancer	7.06e-05	0.00286	CcSEcCtD
Vismodegib—Constipation—Epirubicin—liver cancer	7.06e-05	0.00286	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Doxorubicin—liver cancer	6.96e-05	0.00282	CcSEcCtD
Vismodegib—ABCB1—liver—liver cancer	6.79e-05	0.00763	CbGeAlD
Vismodegib—Gastrointestinal pain—Epirubicin—liver cancer	6.76e-05	0.00273	CcSEcCtD
Vismodegib—Dyspepsia—Doxorubicin—liver cancer	6.73e-05	0.00272	CcSEcCtD
Vismodegib—Decreased appetite—Doxorubicin—liver cancer	6.65e-05	0.00269	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Doxorubicin—liver cancer	6.6e-05	0.00267	CcSEcCtD
Vismodegib—Fatigue—Doxorubicin—liver cancer	6.59e-05	0.00266	CcSEcCtD
Vismodegib—Pain—Doxorubicin—liver cancer	6.54e-05	0.00264	CcSEcCtD
Vismodegib—Constipation—Doxorubicin—liver cancer	6.54e-05	0.00264	CcSEcCtD
Vismodegib—Abdominal pain—Epirubicin—liver cancer	6.53e-05	0.00264	CcSEcCtD
Vismodegib—Gastrointestinal pain—Doxorubicin—liver cancer	6.25e-05	0.00253	CcSEcCtD
Vismodegib—Abdominal pain—Doxorubicin—liver cancer	6.04e-05	0.00244	CcSEcCtD
Vismodegib—Asthenia—Epirubicin—liver cancer	5.93e-05	0.0024	CcSEcCtD
Vismodegib—Pruritus—Epirubicin—liver cancer	5.84e-05	0.00236	CcSEcCtD
Vismodegib—Diarrhoea—Epirubicin—liver cancer	5.65e-05	0.00229	CcSEcCtD
Vismodegib—Asthenia—Doxorubicin—liver cancer	5.48e-05	0.00222	CcSEcCtD
Vismodegib—Pruritus—Doxorubicin—liver cancer	5.41e-05	0.00219	CcSEcCtD
Vismodegib—Vomiting—Epirubicin—liver cancer	5.25e-05	0.00212	CcSEcCtD
Vismodegib—Diarrhoea—Doxorubicin—liver cancer	5.23e-05	0.00211	CcSEcCtD
Vismodegib—Rash—Epirubicin—liver cancer	5.21e-05	0.00211	CcSEcCtD
Vismodegib—Dermatitis—Epirubicin—liver cancer	5.2e-05	0.0021	CcSEcCtD
Vismodegib—Nausea—Epirubicin—liver cancer	4.91e-05	0.00198	CcSEcCtD
Vismodegib—Vomiting—Doxorubicin—liver cancer	4.86e-05	0.00197	CcSEcCtD
Vismodegib—Rash—Doxorubicin—liver cancer	4.82e-05	0.00195	CcSEcCtD
Vismodegib—Dermatitis—Doxorubicin—liver cancer	4.82e-05	0.00195	CcSEcCtD
Vismodegib—Nausea—Doxorubicin—liver cancer	4.54e-05	0.00184	CcSEcCtD
Vismodegib—SMO—Signaling Pathways—KRAS—liver cancer	5.97e-06	0.000134	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—NAT2—liver cancer	5.96e-06	0.000134	CbGpPWpGaD
Vismodegib—ALB—Metabolism—NAT2—liver cancer	5.93e-06	0.000133	CbGpPWpGaD
Vismodegib—ABCG2—Transmembrane transport of small molecules—RAF1—liver cancer	5.91e-06	0.000133	CbGpPWpGaD
Vismodegib—ABCB1—Transmembrane transport of small molecules—HMOX1—liver cancer	5.88e-06	0.000132	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—CYCS—liver cancer	5.86e-06	0.000132	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—TAT—liver cancer	5.84e-06	0.000131	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—NR1H4—liver cancer	5.81e-06	0.00013	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—MAPK14—liver cancer	5.78e-06	0.00013	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—PIK3CA—liver cancer	5.78e-06	0.00013	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—GOT1—liver cancer	5.75e-06	0.000129	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—GGT1—liver cancer	5.75e-06	0.000129	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—liver cancer	5.73e-06	0.000129	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—GSTA4—liver cancer	5.73e-06	0.000129	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—ALDOB—liver cancer	5.72e-06	0.000128	CbGpPWpGaD
Vismodegib—ALB—Platelet activation, signaling and aggregation—TGFB1—liver cancer	5.71e-06	0.000128	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—GSTA3—liver cancer	5.71e-06	0.000128	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—PPARA—liver cancer	5.7e-06	0.000128	CbGpPWpGaD
Vismodegib—ALB—Metabolism—ALDOB—liver cancer	5.68e-06	0.000128	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	5.64e-06	0.000127	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	5.62e-06	0.000126	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—F2—liver cancer	5.6e-06	0.000126	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	5.6e-06	0.000126	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—TP53—liver cancer	5.59e-06	0.000126	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—GSTA4—liver cancer	5.59e-06	0.000126	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—GSTA2—liver cancer	5.58e-06	0.000125	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—PIK3CA—liver cancer	5.48e-06	0.000123	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—CRABP1—liver cancer	5.45e-06	0.000123	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—GSTA2—liver cancer	5.45e-06	0.000122	CbGpPWpGaD
Vismodegib—ALB—Metabolism—CRABP1—liver cancer	5.42e-06	0.000122	CbGpPWpGaD
Vismodegib—ALB—Transmembrane transport of small molecules—PPARA—liver cancer	5.42e-06	0.000122	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—GSTA1—liver cancer	5.38e-06	0.000121	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—PIK3CG—liver cancer	5.36e-06	0.000121	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—HRAS—liver cancer	5.35e-06	0.00012	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—NAT2—liver cancer	5.32e-06	0.00012	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—TP53—liver cancer	5.3e-06	0.000119	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—GSTA1—liver cancer	5.25e-06	0.000118	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	5.25e-06	0.000118	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—GSTA4—liver cancer	5.22e-06	0.000117	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	5.21e-06	0.000117	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—NAT2—liver cancer	5.2e-06	0.000117	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—GSTP1—liver cancer	5.16e-06	0.000116	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—IL6—liver cancer	5.12e-06	0.000115	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—liver cancer	5.12e-06	0.000115	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—ALDOB—liver cancer	5.1e-06	0.000115	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	5.1e-06	0.000115	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—HMOX1—liver cancer	5.09e-06	0.000114	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—GSTA2—liver cancer	5.09e-06	0.000114	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—HRAS—liver cancer	5.07e-06	0.000114	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—ALDOB—liver cancer	4.98e-06	0.000112	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	4.91e-06	0.00011	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—GSTA1—liver cancer	4.91e-06	0.00011	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	4.88e-06	0.00011	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—CRABP1—liver cancer	4.87e-06	0.000109	CbGpPWpGaD
Vismodegib—ALB—Platelet activation, signaling and aggregation—PIK3CA—liver cancer	4.86e-06	0.000109	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—IL6—liver cancer	4.85e-06	0.000109	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—NAT2—liver cancer	4.85e-06	0.000109	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	4.79e-06	0.000108	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—HPGDS—liver cancer	4.77e-06	0.000107	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—CRABP1—liver cancer	4.75e-06	0.000107	CbGpPWpGaD
Vismodegib—ABCB1—Transmembrane transport of small molecules—PPARA—liver cancer	4.75e-06	0.000107	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—GSTM1—liver cancer	4.75e-06	0.000107	CbGpPWpGaD
Vismodegib—ALB—Metabolism—HPGDS—liver cancer	4.74e-06	0.000107	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—liver cancer	4.74e-06	0.000107	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—AKT1—liver cancer	4.72e-06	0.000106	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—PIK3CD—liver cancer	4.71e-06	0.000106	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—PPARG—liver cancer	4.71e-06	0.000106	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—liver cancer	4.67e-06	0.000105	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—SERPINE1—liver cancer	4.66e-06	0.000105	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—ALDOB—liver cancer	4.65e-06	0.000105	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	4.63e-06	0.000104	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—CYP1A1—liver cancer	4.5e-06	0.000101	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—AKT1—liver cancer	4.48e-06	0.000101	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—CRABP1—liver cancer	4.44e-06	9.98e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	4.38e-06	9.85e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	4.32e-06	9.7e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	4.29e-06	9.65e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—ALB—liver cancer	4.26e-06	9.58e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—HPGDS—liver cancer	4.26e-06	9.56e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—PSMA4—liver cancer	4.25e-06	9.55e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—PSMD10—liver cancer	4.25e-06	9.55e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—liver cancer	4.23e-06	9.51e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—PSMD10—liver cancer	4.22e-06	9.5e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—PSMA4—liver cancer	4.22e-06	9.5e-05	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—RAF1—liver cancer	4.21e-06	9.46e-05	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—MTHFR—liver cancer	4.19e-06	9.43e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—HPGDS—liver cancer	4.15e-06	9.33e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—GOT2—liver cancer	4.13e-06	9.29e-05	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—PPARA—liver cancer	4.11e-06	9.25e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—GOT2—liver cancer	4.11e-06	9.24e-05	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—PIK3CB—liver cancer	4.11e-06	9.24e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	4e-06	8.98e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—GLUL—liver cancer	3.97e-06	8.92e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—CPT1B—liver cancer	3.97e-06	8.92e-05	CbGpPWpGaD
Vismodegib—ALB—Platelet activation, signaling and aggregation—AKT1—liver cancer	3.97e-06	8.92e-05	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	3.91e-06	8.79e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—CYP2E1—liver cancer	3.89e-06	8.73e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—HPGDS—liver cancer	3.88e-06	8.72e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—CYP2E1—liver cancer	3.86e-06	8.68e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	3.86e-06	8.67e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	3.85e-06	8.66e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—NR1H4—liver cancer	3.83e-06	8.61e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—ALB—liver cancer	3.8e-06	8.55e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—PSMA4—liver cancer	3.79e-06	8.52e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—PSMD10—liver cancer	3.79e-06	8.52e-05	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—IL2—liver cancer	3.77e-06	8.48e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—GSTA3—liver cancer	3.76e-06	8.46e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	3.76e-06	8.46e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	3.74e-06	8.41e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—PSMA4—liver cancer	3.7e-06	8.32e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—PSMD10—liver cancer	3.7e-06	8.32e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—GOT2—liver cancer	3.69e-06	8.29e-05	CbGpPWpGaD
Vismodegib—ALB—Transmembrane transport of small molecules—RAF1—liver cancer	3.64e-06	8.19e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—CYCS—liver cancer	3.64e-06	8.17e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—CYCS—liver cancer	3.62e-06	8.13e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—GOT2—liver cancer	3.6e-06	8.09e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—GOT1—liver cancer	3.57e-06	8.02e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—GGT1—liver cancer	3.57e-06	8.02e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—GOT1—liver cancer	3.55e-06	7.97e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—GGT1—liver cancer	3.55e-06	7.97e-05	CbGpPWpGaD
Vismodegib—ABCB1—Transmembrane transport of small molecules—ALB—liver cancer	3.53e-06	7.93e-05	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—PIK3CG—liver cancer	3.52e-06	7.92e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	3.51e-06	7.9e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—CYP2E1—liver cancer	3.47e-06	7.8e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	3.47e-06	7.8e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—PSMA4—liver cancer	3.46e-06	7.77e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—PSMD10—liver cancer	3.46e-06	7.77e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—GSTA4—liver cancer	3.44e-06	7.74e-05	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—PPARG—liver cancer	3.4e-06	7.64e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—CYP2E1—liver cancer	3.39e-06	7.61e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—GOT2—liver cancer	3.36e-06	7.56e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	3.36e-06	7.55e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—GSTA2—liver cancer	3.36e-06	7.54e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—CYCS—liver cancer	3.25e-06	7.29e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—GSTA1—liver cancer	3.24e-06	7.28e-05	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—VEGFA—liver cancer	3.21e-06	7.21e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—GSTP1—liver cancer	3.2e-06	7.2e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—NAT2—liver cancer	3.2e-06	7.19e-05	CbGpPWpGaD
Vismodegib—ABCB1—Transmembrane transport of small molecules—RAF1—liver cancer	3.19e-06	7.18e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—GSTP1—liver cancer	3.19e-06	7.16e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—GGT1—liver cancer	3.18e-06	7.16e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—GOT1—liver cancer	3.18e-06	7.16e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—CYCS—liver cancer	3.17e-06	7.12e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—CYP2E1—liver cancer	3.16e-06	7.11e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—HMOX1—liver cancer	3.16e-06	7.1e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—HMOX1—liver cancer	3.14e-06	7.06e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—GGT1—liver cancer	3.11e-06	6.99e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—GOT1—liver cancer	3.11e-06	6.99e-05	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—PIK3CD—liver cancer	3.1e-06	6.96e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—ALDOB—liver cancer	3.07e-06	6.9e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	3.06e-06	6.88e-05	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—ALB—liver cancer	3.06e-06	6.87e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—CYCS—liver cancer	2.96e-06	6.65e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—GSTM1—liver cancer	2.95e-06	6.62e-05	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—TGFB1—liver cancer	2.94e-06	6.62e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—GSTM1—liver cancer	2.93e-06	6.58e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—CRABP1—liver cancer	2.93e-06	6.58e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—GOT1—liver cancer	2.9e-06	6.53e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—GGT1—liver cancer	2.9e-06	6.53e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—GSTP1—liver cancer	2.86e-06	6.43e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—HMOX1—liver cancer	2.82e-06	6.34e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—GSTP1—liver cancer	2.79e-06	6.28e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—CYP1A1—liver cancer	2.79e-06	6.28e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—CYP1A1—liver cancer	2.78e-06	6.24e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—HMOX1—liver cancer	2.75e-06	6.19e-05	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—KRAS—liver cancer	2.73e-06	6.13e-05	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—PIK3CB—liver cancer	2.7e-06	6.07e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—GSTM1—liver cancer	2.63e-06	5.91e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—GSTP1—liver cancer	2.61e-06	5.86e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—MTHFR—liver cancer	2.6e-06	5.85e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—MTHFR—liver cancer	2.59e-06	5.82e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—HMOX1—liver cancer	2.57e-06	5.78e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—GSTM1—liver cancer	2.57e-06	5.77e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—HPGDS—liver cancer	2.56e-06	5.75e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—PPARA—liver cancer	2.55e-06	5.74e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—PPARA—liver cancer	2.54e-06	5.71e-05	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—PIK3CA—liver cancer	2.51e-06	5.63e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—CYP1A1—liver cancer	2.49e-06	5.6e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—CYP1A1—liver cancer	2.43e-06	5.47e-05	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—TP53—liver cancer	2.42e-06	5.45e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—GSTM1—liver cancer	2.4e-06	5.39e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—MTHFR—liver cancer	2.32e-06	5.22e-05	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—HRAS—liver cancer	2.32e-06	5.21e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.29e-06	5.16e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.28e-06	5.13e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—PSMD10—liver cancer	2.28e-06	5.13e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—PSMA4—liver cancer	2.28e-06	5.13e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—PPARA—liver cancer	2.28e-06	5.12e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—CYP1A1—liver cancer	2.27e-06	5.11e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—MTHFR—liver cancer	2.27e-06	5.1e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—PPARA—liver cancer	2.22e-06	5e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—GOT2—liver cancer	2.22e-06	4.99e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—PIK3CG—liver cancer	2.19e-06	4.92e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—PIK3CG—liver cancer	2.17e-06	4.89e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—MTHFR—liver cancer	2.12e-06	4.76e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—PPARG—liver cancer	2.11e-06	4.74e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—PPARG—liver cancer	2.1e-06	4.72e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—CYP2E1—liver cancer	2.09e-06	4.69e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—PPARA—liver cancer	2.08e-06	4.67e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.05e-06	4.6e-05	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—AKT1—liver cancer	2.05e-06	4.6e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—PIK3CG—liver cancer	1.95e-06	4.39e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—CYCS—liver cancer	1.95e-06	4.39e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—PIK3CD—liver cancer	1.92e-06	4.32e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—GOT1—liver cancer	1.92e-06	4.3e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—GGT1—liver cancer	1.92e-06	4.3e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—PIK3CD—liver cancer	1.91e-06	4.3e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—PIK3CG—liver cancer	1.91e-06	4.28e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—ALB—liver cancer	1.9e-06	4.27e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—PPARG—liver cancer	1.88e-06	4.23e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.87e-06	4.2e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—PPARG—liver cancer	1.84e-06	4.13e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—PIK3CG—liver cancer	1.78e-06	4e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—GSTP1—liver cancer	1.72e-06	3.87e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—PPARG—liver cancer	1.72e-06	3.86e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—PIK3CD—liver cancer	1.72e-06	3.86e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—HMOX1—liver cancer	1.7e-06	3.81e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—ALB—liver cancer	1.69e-06	3.81e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—PIK3CB—liver cancer	1.68e-06	3.77e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—PIK3CD—liver cancer	1.67e-06	3.76e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—PIK3CB—liver cancer	1.67e-06	3.74e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—ALB—liver cancer	1.65e-06	3.72e-05	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—PIK3CA—liver cancer	1.65e-06	3.7e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—GSTM1—liver cancer	1.58e-06	3.55e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—PIK3CD—liver cancer	1.56e-06	3.52e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—ALB—liver cancer	1.54e-06	3.47e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—CYP1A1—liver cancer	1.5e-06	3.37e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—PIK3CB—liver cancer	1.5e-06	3.36e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—PIK3CB—liver cancer	1.46e-06	3.28e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—MTHFR—liver cancer	1.4e-06	3.14e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—PPARA—liver cancer	1.37e-06	3.08e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—PIK3CB—liver cancer	1.36e-06	3.07e-05	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—AKT1—liver cancer	1.34e-06	3.02e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—PIK3CG—liver cancer	1.17e-06	2.64e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—PPARG—liver cancer	1.13e-06	2.55e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—PIK3CD—liver cancer	1.03e-06	2.32e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—PIK3CA—liver cancer	1.02e-06	2.3e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—ALB—liver cancer	1.02e-06	2.29e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—PIK3CA—liver cancer	1.02e-06	2.28e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—PIK3CA—liver cancer	9.12e-07	2.05e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—PIK3CB—liver cancer	8.99e-07	2.02e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—PIK3CA—liver cancer	8.9e-07	2e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—AKT1—liver cancer	8.35e-07	1.88e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—PIK3CA—liver cancer	8.31e-07	1.87e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—AKT1—liver cancer	8.3e-07	1.86e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—AKT1—liver cancer	7.45e-07	1.67e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—AKT1—liver cancer	7.27e-07	1.63e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—AKT1—liver cancer	6.79e-07	1.53e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—PIK3CA—liver cancer	5.48e-07	1.23e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—AKT1—liver cancer	4.48e-07	1.01e-05	CbGpPWpGaD
